Enoxaparin sodium and Right ventricular failure - a phase IV clinical study of FDA data
Summary:
Right ventricular failure is reported as a side effect among people who take Enoxaparin sodium (enoxaparin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Tracleer, and have Primary pulmonary hypertension.
The phase IV clinical study analyzes which people have Right ventricular failure when taking Enoxaparin sodium. It is created by eHealthMe based on reports of 24,091 people who have side effects when taking Enoxaparin sodium from the FDA, and is updated regularly.
What is Enoxaparin sodium?
Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.
What is Right ventricular failure?
Right ventricular failure (right half of the heart fails to work) is found to be associated with 589 drugs and 718 conditions by eHealthMe. Check the latest studies of Right ventricular failure.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
24,091 people reported to have side effects when taking Enoxaparin sodium.
Among them, 35 people (0.15%) have Right ventricular failure.

Among these 35 people:
How long have people been on Enoxaparin sodium when they have Right ventricular failure? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Right ventricular failure when taking Enoxaparin sodium? *
- female: 64.29 %
- male: 35.71 %
What is the age of people who have Right ventricular failure when taking Enoxaparin sodium? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 3.7 %
- 20-29: 14.81 %
- 30-39: 18.52 %
- 40-49: 3.7 %
- 50-59: 14.81 %
- 60+: 44.44 %
What are other drugs people take besides Enoxaparin sodium? *
- Tracleer: 9 people, 25.71%
- Ventavis: 8 people, 22.86%
- Torsemide: 8 people, 22.86%
- Revatio: 7 people, 20.00%
- Heparin: 5 people, 14.29%
- Ramipril: 5 people, 14.29%
- Calcitriol: 5 people, 14.29%
- Furosemide: 5 people, 14.29%
- Digoxin: 4 people, 11.43%
- Alprazolam: 3 people, 8.57%
What are other side effects people have besides Right ventricular failure? *
- Acute Kidney Failure: 12 people, 34.29%
- Pulmonary Embolism (blockage of the main artery of the lung): 10 people, 28.57%
- Anaemia (lack of blood): 9 people, 25.71%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 20.00%
- Dyspnea (difficult or laboured breathing): 7 people, 20.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 17.14%
- Urinary Tract Infection: 6 people, 17.14%
- Pleural Effusion (water on the lungs): 6 people, 17.14%
- Disease Progression: 6 people, 17.14%
- Nosebleed (bleeding from nose): 5 people, 14.29%
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 9 people, 25.71%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 11.43%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 8.57%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 5.71%
- Chronic Renal Failure (kidney failure): 2 people, 5.71%
- Fibrin D Dimer Increased: 2 people, 5.71%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 5.71%
- Neuropsychiatric Lupus (the various psychiatric and neurologic symptoms due to a multi system inflammatory disorder): 2 people, 5.71%
- Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 5.71%
- Superinfection: 1 person, 2.86%
* Approximation only. Some reports may have incomplete information.
Do you take Enoxaparin sodium and have Right ventricular failure?
- Check whether Right ventricular failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Enoxaparin sodium:
- Enoxaparin sodium (24,181 reports)
Right ventricular failure treatments and more:
- Right ventricular failure (10,162 reports)
How severe was Right ventricular failure and when was it recovered:
Expand to all the drugs that have ingredients of enoxaparin sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Enoxaparin sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Right ventricular failure:
- Right ventricular failure (589 drugs)
Browse all the conditions that are associated with Right ventricular failure:
- Right ventricular failure (718 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Enoxaparin sodium) and Enoxaparin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ventavis cause Pleural Effusion? - 4 seconds ago
- Could Venlafaxine Hydrochloride cause Hepatic Mass? - 9 seconds ago
- Could Orencia cause Osteoarthritis Aggravated? - 38 seconds ago
- Could Velphoro cause Intestinal Obstruction? - 42 seconds ago
- Could Glynase cause Hyponatraemia Aggravated? - 45 seconds ago
- Could Biotin cause Hypotonia? - 47 seconds ago
- Could Orencia cause Vaginal Ulceration? - 53 seconds ago
- Could Biotin cause Herpes Simplex Aggravated? - 56 seconds ago
- Could Januvia cause Cervix Carcinoma? - a minute ago
- Could Biaxin cause Stress And Anxiety? - a minute ago